首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CFD Recombinant Antibody

Anti-Human CFD Recombinant Antibody

产品编号

YR1282

别名

科研级 Lampalizumab ( 兰帕利珠单抗 ), Anti-CFD Recombinant Antibody, Research Grade Lampalizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Lampalizumab ( 兰帕利珠单抗 ), Anti-CFD Recombinant Antibody, Research Grade Lampalizumab
Catalog NumberYR1282
Molecular NameLampalizumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeFab-G1 Kappa
FormulationPBS, pH7.5
BackgroundLampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D, it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration.
CAS Number1278466-20-8
ApplicationELISA, IP, FCM, FuncS, Neut, IF, Stim
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCFD[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价